Figure 1From: Renal function during rofecoxib therapy in patients with metastatic cancer: retrospective analysis of a prospective phase II trialChange of serum creatinine concentrations during therapy. Increase of serum creatinine concentrations ± SEM compared to baseline (0.81, ± 0.28 mg/dl) during therapy with rofecoxib. *: p < 0.05.Back to article page